Skip to content
Alvászavarok

Alvászavarok kezelések

Bongéssze az elérheeto alvászavarok kezeléseket. Mindegyik tartalmazza a fuggetlen EU-s orvos felulvizsgalatát, eredeti gyogyszereket engedélyes gyogyszertarakbol és diszkret expressz kézbesitést.

2026-04-12 Kezelések

Interested in Alvászavarok?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Sleep disorder kezelések Európában

Sleep disorders represent a significant and growing public health burden across the European Union. Insomnia — characterised by persistent difficulty falling asleep, staying asleep, or waking too early, with consequent daytime impairment — is estimated to affect between 10% and 30% of the adult European population. When accounting for sub-threshold sleep disturbance, the figure is considerably higher.

The consequences of inadequate sleep extend well beyond fatigue. Chronic insomnia is associated with increased risk of cardiovascular disease, metabolic disorders including type 2 diabetes, depression, anxiety, and impaired cognitive function. Occupational and road safety risks associated with sleep deprivation impose significant societal costs.

Sleep disorders exist on a spectrum. Transient or short-term insomnia, often related to stress, travel, or life events, frequently resolves without pharmacological intervention. Chronic insomnia — defined as occurring at least three nights per week for at least three months — is a recognised medical condition warranting clinical evaluation and, where appropriate, treatment.

International clinical guidelines, including those from the European Sleep Research Society, recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia. Pharmacological treatments may be appropriate for short-term management or when CBT-I is unavailable or insufficient. Prescription sleep medications include melatonin (approved for certain indications), and sedative-hypnotic agents (Z-drugs) such as zopiclone and zolpidem.

It is important that any prescription for sleep medication be accompanied by assessment for underlying causes, including sleep apnoea, depression, anxiety, or medication side effects. A qualified, independent doctor is best placed to determine the appropriate treatment pathway.

Elérhető kezelések

The following medications may be available for sleep disorders through EU-registered doctors. This comparison is provided for informational purposes only.

MedicationActive IngredientClassTypical Use
Melatonin (prescription)MelatoninChronobiotic hormoneCircadian rhythm disorders, older adults with insomnia
ZopicloneZopicloneZ-drug (sedative-hypnotic)Short-term insomnia
ZolpidemZolpidem tartrateZ-drug (sedative-hypnotic)Short-term insomnia

Key distinctions:

  • Melatonin: A physiological hormone rather than a sedative. Primarily regulates circadian rhythm. EMA-approved for short-term treatment of insomnia in patients over 55, and for jet lag. Lower dependence risk than Z-drugs.
  • Zopiclone: A cyclopyrrolone that enhances GABA activity, producing sedation. Standard prescription duration is typically 2–4 weeks. Carries risks of tolerance, dependence, and morning residual sedation.
  • Zolpidem: An imidazopyridine with similar mechanism to zopiclone. Sleep-onset focused. European regulators have lowered recommended doses (particularly for women) due to next-morning impairment data.

Hogyan szerezhető be a kezelések online

A Prescrivia technológiai közvetítőként működik: nem írunk fel gyógyszereket, nem alkalmazunk orvosokat és nem értékesítünk gyógyszereket. Platformunk pácienseket kapcsol össze független, EU-ban regisztrált orvosokkal, akik bizalmas online egészségügyi felméréseket végezhetnek.

A folyamat a következő:

  1. Töltse ki az egészségügyi kérdőívet — Answer a structured set of medical questions covering your sleep patterns, duration of difficulties, sleep environment, mental health history, current medications, and any previous treatment for sleep disorders.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a prescription sleep medication is clinically appropriate for a short-term period, the doctor may issue a prescription. If other factors indicate a different approach is warranted, the doctor will advise accordingly.

  3. Recept és teljesítés — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The pharmacy dispenses the medication and arranges delivery to your address.

Fontos: A Prescrivia nem garantálja a recept kiállítását. Minden felírási döntést független, képzett orvosok hoznak az Ön egyéni klinikai körülményei alapján. Z-drugs are controlled substances in many EU member states and are subject to strict prescribing restrictions.

Összehasonlításunk

A Prescrivia-n keresztülSzemélyes orvosi konzultáció
Elérhetőség24/7 online assessmentSubject to appointment availability
Várakozási időAssessment reviewed within hoursDays to weeks depending on location
Utazás szükségesNoYes
Felírási döntésMade by independent EU-registered doctorMade by your GP
Ongoing monitoringSupported via follow-up assessmentsManaged by your GP
KöltségTransparent pricing displayed upfrontVaries by country and healthcare system

Note: Sleep disorders associated with sleep apnoea, restless legs syndrome, narcolepsy, or significant psychiatric comorbidity require specialist evaluation. Prescrivia’s platform is designed for adults with primary short-term insomnia suitable for remote assessment. Long-term management of chronic insomnia should ideally involve CBT-I delivered by a qualified practitioner.

Források

Az oldalon található orvosi információk az alábbi forrásokon alapulnak:

  • European Medicines Agency (EMA). Circadin (melatonin) — Summary of Product Characteristics. Available at: ema.europa.eu
  • Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research. 2017;26(6):675-700.
  • World Health Organization (WHO). Sleep and health — WHO Fact Sheet. who.int

Ez a tartalom rendszeresen felülvizsgálatra kerül a frissített klinikai irányelvek tükrözése érdekében. Kizárólag tájékoztató jelleggel készült, és nem minősül orvosi tanácsadásnak. Mindig konzultáljon képzett egészségügyi szakemberrel az Ön egyéni egészségügyi körülményeire vonatkozó tanácsért.

Frequently asked questions

Megkaphatom a Alvászavarok készítményt online Európában?
A készítményhez online közvetítő platformokon keresztül férhet hozzá, amelyek független, EU-ban regisztrált orvosokkal kötik össze Önt. A bizalmas egészségügyi kérdőív kitöltése után az orvos felméri, hogy a gyógyszer klinikailag megfelelő-e az Ön számára.
Mi a különbség between melatonin and zopiclone or zolpidem?
Melatonin is a hormone naturally produced by the body that regulates the sleep-wake cycle. Prescription melatonin is primarily used for circadian rhythm disturbances and jet lag, and for older adults with insomnia. Zopiclone and zolpidem are sedative-hypnotic drugs (Z-drugs) that act on GABA receptors to induce sleep. They are more potent and carry greater risk of dependence.
Mennyi ideig can I take zopiclone or zolpidem?
Z-drugs such as zopiclone and zolpidem are generally recommended for short-term use only — typically 2 to 4 weeks — due to risks of tolerance, dependence, and withdrawal. European clinical guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia.
Is melatonin available without a prescription in Europe?
Melatonin's regulatory status varies across EU member states. In some countries it is available as an over-the-counter supplement; in others, including Germany and Ireland, prescription-strength melatonin requires a doctor's prescription. An independent doctor can assess what is appropriate for your situation.
What information do I need to provide for a sleep disorder assessment?
You will typically be asked about the nature of your sleep difficulties, how long they have persisted, any identified triggers, your current medications, medical history (including mental health history), and whether you have been evaluated for conditions such as sleep apnoea. This allows the reviewing doctor to make a safe clinical decision.
A Prescrivia közvetítő platform. Nem nyújtunk orvosi szolgáltatásokat, nem írunk fel kezeléseket és nem adunk ki gyógyszereket. Minden orvosi döntést független, EU-ban regisztrált orvosok hoznak. Minden gyógyszert engedéllyel rendelkező EU-gyógyszertárak adnak ki. Ez a platform összeköti a betegeket és az egészségügyi szolgáltatókat.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Készen áll a kezdésre?

Töltse ki a bizalmas egészségügyi felmérést körülbelül 3 perc alatt.